PH23711A - Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of inflammatory disease - Google Patents

Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of inflammatory disease

Info

Publication number
PH23711A
PH23711A PH35418A PH35418A PH23711A PH 23711 A PH23711 A PH 23711A PH 35418 A PH35418 A PH 35418A PH 35418 A PH35418 A PH 35418A PH 23711 A PH23711 A PH 23711A
Authority
PH
Philippines
Prior art keywords
treatment
inflammatory disease
substituted ethers
oxabicycloheptane substituted
hydroximic acids
Prior art date
Application number
PH35418A
Other languages
English (en)
Inventor
Ravi Kannadikovilakom Varma
Eric Michael Gordon
Ligaya Magbanua Simpkins
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of PH23711A publication Critical patent/PH23711A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH35418A 1986-07-23 1987-06-17 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of inflammatory disease PH23711A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/888,671 US4673685A (en) 1986-07-23 1986-07-23 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Publications (1)

Publication Number Publication Date
PH23711A true PH23711A (en) 1989-09-27

Family

ID=25393633

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35418A PH23711A (en) 1986-07-23 1987-06-17 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of inflammatory disease

Country Status (29)

Country Link
US (1) US4673685A (fr)
JP (1) JP2557894B2 (fr)
KR (1) KR950010596B1 (fr)
AT (1) AT397094B (fr)
AU (1) AU599384B2 (fr)
BE (1) BE1000141A3 (fr)
CA (1) CA1292003C (fr)
CH (1) CH674010A5 (fr)
DD (1) DD263990A5 (fr)
DE (1) DE3724152A1 (fr)
DK (1) DK383587A (fr)
ES (1) ES2006784A6 (fr)
FI (1) FI873207A (fr)
FR (1) FR2601953B1 (fr)
GB (1) GB2192882B (fr)
GR (1) GR871147B (fr)
HU (1) HU198495B (fr)
IE (1) IE60487B1 (fr)
IL (1) IL82919A0 (fr)
IT (1) IT1222054B (fr)
LU (1) LU86949A1 (fr)
NL (1) NL8701742A (fr)
NO (1) NO168359C (fr)
NZ (1) NZ220677A (fr)
PH (1) PH23711A (fr)
PT (1) PT85381B (fr)
SE (1) SE8702936L (fr)
YU (1) YU46321B (fr)
ZA (1) ZA874255B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
AU593316B2 (en) * 1986-02-14 1990-02-08 E.R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5093329A (en) * 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242273A (en) * 1977-09-27 1980-12-30 American Cyanamid Company 4-(Monoalkylamino)benzoic acid amides and imidates
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
EP0045118B1 (fr) * 1979-01-05 1984-04-04 National Research Development Corporation Intermédiaires pour la synthèse de bicyclo (2,2,1) heptanes et bicyclo (2,2,1) hept-2Z-ènes
US4440940A (en) * 1979-10-17 1984-04-03 American Cyanamid Company Anti-atherosclerotic agents
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
EP0082646B1 (fr) * 1981-12-23 1989-11-15 National Research Development Corporation Prostaglandines
US4466979A (en) * 1983-01-21 1984-08-21 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (fr) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptanes substitues analogues de prostaglandines
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
US4513103A (en) * 1983-10-21 1985-04-23 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4661506A (en) * 1984-11-30 1987-04-28 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted ox prostaglandin analogs
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4652578A (en) * 1986-02-24 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
HU198495B (en) 1989-10-30
HUT47115A (en) 1989-01-30
AU7444887A (en) 1988-01-28
JPS6335576A (ja) 1988-02-16
AT397094B (de) 1994-01-25
ATA174887A (de) 1993-06-15
NO873069L (no) 1988-01-25
YU46321B (sh) 1993-05-28
ES2006784A6 (es) 1989-05-16
KR950010596B1 (ko) 1995-09-20
US4673685A (en) 1987-06-16
NO168359B (no) 1991-11-04
IE871675L (en) 1988-01-23
LU86949A1 (fr) 1988-02-02
IE60487B1 (en) 1994-07-27
DK383587D0 (da) 1987-07-22
CH674010A5 (fr) 1990-04-30
IT1222054B (it) 1990-08-31
GR871147B (en) 1987-12-04
FI873207A0 (fi) 1987-07-21
NO873069D0 (no) 1987-07-22
IL82919A0 (en) 1987-12-20
SE8702936L (sv) 1988-04-07
PT85381A (en) 1987-08-01
PT85381B (pt) 1990-04-30
FI873207A (fi) 1988-01-24
DK383587A (da) 1988-01-24
GB8714621D0 (en) 1987-07-29
NZ220677A (en) 1989-12-21
CA1292003C (fr) 1991-11-12
NL8701742A (nl) 1988-02-16
GB2192882A (en) 1988-01-27
FR2601953A1 (fr) 1988-01-29
BE1000141A3 (fr) 1988-05-03
YU138187A (en) 1988-12-31
JP2557894B2 (ja) 1996-11-27
IT8721328A0 (it) 1987-07-16
KR880001660A (ko) 1988-04-25
NO168359C (no) 1992-02-12
DD263990A5 (de) 1989-01-18
SE8702936D0 (sv) 1987-07-22
FR2601953B1 (fr) 1990-11-16
DE3724152A1 (de) 1988-02-04
AU599384B2 (en) 1990-07-19
GB2192882B (en) 1990-05-09
ZA874255B (en) 1988-02-24

Similar Documents

Publication Publication Date Title
GB2195632B (en) 4,6-orthoesters of sucrose and their use in the preparation of sucrose-6-acylates
ZA85206B (en) Protein conjugates useful in the treatment of thrombotic disease
EP0205579A4 (fr) Procedes et compositions utiles pour le diagnostic et le traitement de maladies autoimmunitaires.
IL83444A0 (en) Sweetmeats and their manufacture
EP0243968A3 (en) Diacetylrhein salts and their therapeutical use in the treatment of arthritis
JPS6454032A (en) Polydisilacyclobutasilazane and its preparation and use
GB8908831D0 (en) Treatment of inflammatory disorders in humans
KR890701004A (ko) 개선된 생리효과를 가지는 식물의 제조 및 이 식물의 용도
PH23711A (en) Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of inflammatory disease
EP0298706A3 (en) Glycans and their use as anti-viral agents
ZA834344B (en) Use of 1,4-dihydropyridines in antiarteriosclerotic agents and their preparation
GB2201171B (en) Compositions for use in the treatment of cellulosic materials and their preparation
GB2207270B (en) Improvements in and relating to determining the characteristics of conducting objects
EP0321428A3 (en) Use of glycerol ethers in dermatological diseases
GB8908843D0 (en) Improvements in or relating to the treatment of surfaces
ZA904541B (en) 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospatic disease
ZA87873B (en) Substituted diazapines and derivatives thereof useful in the treatment of cardiovascular disorders
DE3561943D1 (en) Production of para-diisopropylbenzene and use of the same in the production of hydroquinone
SG3490G (en) Alpha-bromodiethylcarbonate and its use in the preparation of antibiotics
IL88566A (en) Composition for the reduction of phlebectasiae and its preparation
GB2130583B (en) Phthalidylammonium compounds and their preparation and their use in the production of 1-phthalidyl-5-fluorouracil derivatives
JPS6466148A (en) Manufacture of 1,5-diaminoheptanol-6, manufacture and use
EP0380985A3 (en) Esters of 4-aryl-2-halogen imidazol-5-carbonic acid, their preparation and use
CY1520A (en) Alpha-bromodiethylcarbonate and its use in the preparation of antibiotics
PL268606A1 (en) Cosmetic preparation in the form of cream